Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
US |
|
Coty Inc
PAR:COTY
|
US |
|
Fresnillo PLC
LSE:FRES
|
MX |
|
Babcock & Wilcox Enterprises Inc
NYSE:BW
|
US |
|
NAPCO Security Technologies Inc
NASDAQ:NSSC
|
US |
|
K
|
Koninklijke Philips NV
MIL:PHIA
|
NL |
|
Triputra Agro Persada Tbk PT
IDX:TAPG
|
ID |
|
Wesco International Inc
NYSE:WCC
|
US |
|
KLX Energy Services Holdings Inc
NASDAQ:KLXE
|
US |
|
Brunello Cucinelli SpA
MIL:BC
|
IT |
|
George Weston Ltd
TSX:WN
|
CA |
|
Ares Commercial Real Estate Corp
NYSE:ACRE
|
US |
|
Xperi Holding Corp
LSE:0M2A
|
US |
|
Ryder System Inc
NYSE:R
|
US |
|
Apogee Enterprises Inc
NASDAQ:APOG
|
US |
|
Easterly Government Properties Inc
NYSE:DEA
|
US |
|
K
|
Kyudenko Corp
TSE:1959
|
JP |
|
F
|
First Tin PLC
LSE:1SN
|
UK |
|
Crescent Biopharma Inc
F:C68
|
US |
|
M
|
Motus Holdings Ltd
JSE:MTH
|
ZA |
Wall St Price Targets
SNOA Price Targets Summary
Sonoma Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
SNOA is 15.1 USD with a low forecast of 14.95 USD and a high forecast of 15.54 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNOA's stock price target?
Price Target
15.1
USD
According to Wall Street analysts, the average 1-year price target for
SNOA is 15.1 USD with a low forecast of 14.95 USD and a high forecast of 15.54 USD.
What is the Revenue forecast for Sonoma Pharmaceuticals Inc?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 24%.